Aminoguanidine Affects Systemic and Lung Inflammation Induced by Lipopolysaccharide in Rats
Overview
Authors
Affiliations
Background: Nitric oxide is a mediator of potential importance in numerous physiological and inflammatory processes in the lung. Aminoguanidine (AG) has been shown to have anti-inflammation and radical scavenging properties. This study aimed to investigate the effects of AG, an iNOS inhibitor, on lipopolysaccharide (LPS)-induced systemic and lung inflammation in rats.
Methods: Male Wistar rats were divided into control, LPS (1 mg/kg/day i.p.), and LPS groups treated with AG 50, 100 or 150 mg/kg/day i.p. for five weeks. Total nitrite concentration, total and differential white blood cells (WBC) count, oxidative stress markers, and the levels of IL-4, IFN-γ, TGF-β1, and PGE2 were assessed in the serum or bronchoalveolar lavage fluid (BALF).
Results: Administration of LPS decreased IL-4 level (p < 0.01) in BALF, total thiol content, superoxide dismutase (SOD) and catalase (CAT) activities (p < 0.001) in BALF and serum, and increased total nitrite, malondialdehyde (MDA), IFN-γ, TGF-β1 and PGE2 (p < 0.001) concentrations in BALF. Pre-treatment with AG increased BALF level of IL-4 and total thiol as well as SOD and CAT activities (p < 0.05 to p < 0.001), but decreased BALF levels of total nitrite, MDA, IFN-γ, TGF-β1, and PGE2 (p < 0.01 to p < 0.001). AG treatment decreased total WBC count, lymphocytes and macrophages in BALF (p < 0.01 to p < 0.001) and improved lung pathological changes including interstitial inflammation and lymphoid infiltration (p < 0.05 to p < 0.001).
Conclusions: AG treatment reduced oxidant markers, inflammatory cytokines and lung pathological changes but increased antioxidants and anti-inflammatory cytokines. Therefore, AG may play a significant protective role against inflammation and oxidative stress that cause lung injury.
Protective effects of myrtenol against paraquat-induced toxicity in rats.
Amin F, Basirat H, Parvaz N, Khademalhosseini M, Hakimizadeh E, Fatemi I BMC Pulm Med. 2025; 25(1):17.
PMID: 39806385 PMC: 11730473. DOI: 10.1186/s12890-025-03484-5.
Behrouz S, Mohammadi M, Sarir H, Boskabady M Front Vet Sci. 2024; 11:1464432.
PMID: 39735585 PMC: 11673985. DOI: 10.3389/fvets.2024.1464432.
Behrouz S, Mohammadi M, Sarir H, Mohammadian Roshan N, Boskabady M Heliyon. 2024; 10(20):e39416.
PMID: 39497967 PMC: 11532301. DOI: 10.1016/j.heliyon.2024.e39416.
Eshaghi Ghalibaf M, Taghavi Zadeh Yazdi M, Mansourian M, Mohammadian Roshan N, Boskabady M Immun Inflamm Dis. 2024; 12(8):e70001.
PMID: 39172009 PMC: 11340013. DOI: 10.1002/iid3.70001.
Therapeutic potential of HUC-MSC-exos primed with IFN-γ against LPS-induced acute lung injury.
Wang C, Jiang C, Yang Y, Xi C, Yin Y, Wu H Iran J Basic Med Sci. 2024; 27(3):375-382.
PMID: 38333754 PMC: 10849211. DOI: 10.22038/IJBMS.2023.74372.16156.